{
    "organizations": [],
    "uuid": "aa9f7085210b48993e7c62abdb0315270cf76895",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-chr-hansen-enters-partnership-to-d/brief-chr-hansen-enters-partnership-to-develop-treatment-for-peanut-allergies-idUSC7N1RG02K",
    "ord_in_thread": 0,
    "title": "BRIEF-Chr. Hansen Enters Partnership To Develop Treatment For Peanut Allergies",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - Chr Hansen Holding A/S:\n* SAYS ENTERS PARTNERSHIP WITH OF ORAL IMMUNOTHERAPY DEVELOPER PROTA THERAPEUTICS TO DEVELOP TREATMENT FOR PEANUT ALLERGIES Further company coverage: (Copenhagen newsroom)\n ",
    "published": "2018-04-18T14:35:00.000+03:00",
    "crawled": "2018-04-19T15:21:14.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "chr",
        "hansen",
        "holding",
        "say",
        "enters",
        "partnership",
        "oral",
        "immunotherapy",
        "developer",
        "prota",
        "therapeutic",
        "develop",
        "treatment",
        "peanut",
        "allergy",
        "company",
        "coverage",
        "copenhagen",
        "newsroom"
    ]
}